1. Metabolic Enzyme/Protease Anti-infection
  2. Proteasome Parasite
  3. 20S Proteasome-IN-4

20S Proteasome-IN-4 (Compound 7) 是一种能透过血脑屏障的、寄生虫选择性的、具有口服活性的 20S proteasome 抑制剂,对 T. b. brucei 20S 蛋白酶体的 IC50 为 6.3 nM。20S Proteasome-IN-4 可用于非洲人类锥虫病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

20S Proteasome-IN-4 Chemical Structure

20S Proteasome-IN-4 Chemical Structure

CAS No. : 2827061-47-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

20S Proteasome-IN-4 (Compound 7) is a brain-penetrant, parasite-selective, orally active 20S proteasome inhibitor with an IC50 of 6.3 nM against T. b. brucei 20S proteasome. 20S Proteasome-IN-4 can be used for the research of human African trypanosomiasis (HAT)[1].

IC50 & Target

IC50: 6.3 nM (T. b. brucei 20S proteasome)[1]

体外研究
(In Vitro)

20S Proteasome-IN-4 (Compound 7) (24 h) inhibits T. b. brucei growth with an EC50 of <2.5 nM[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

20S Proteasome-IN-4 (Compound 7) (3 mg/kg; i.g.; once a day for 4 days) cures a stage I mouse model of human African trypanosomiasis[1].
20S Proteasome-IN-4 (15 mg/kg; i.g.; twice a day for 1 week) cures a stage II mouse model of human African trypanosomiasis[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NMRI mice, hemolymphatic mice model (Stage I)[1]
Dosage: 3 mg/kg
Administration: Oral gavage, once a day for 4 days
Result: Achieved complete cure of the stage I infection.
Animal Model: CD1 mice, meningoncephalic mice model (stage II)[1]
Dosage: 15 mg/kg
Administration: Oral gavage, twice a day for 1 week
Result: Achieved complete cure of the stage II infection.
Animal Model: BALB/c mice and Wistar rats[1]
Dosage: 1 mg/kg or 3 mg/kg
Administration: Intravenous or oral administration (Pharmacokinetic Analysis)
Result: ADME and PK Data for 20S Proteasome-IN-4 (Compound 7)[1]
cmp solubility pH 6.8 μM LM CLint (m/r) [μL/min/mg] LM scaled CLint [mL/min/kg] (m/r) fu plasma [%] (m/r) CLp [mL/min/kg] (m/r) CLu [mL/min/kg] (m/r) AUCPO [μM•h] (m/r) AUCIV [μM•h] (m/r) %F m/r
20S Proteasome-IN-4 12 79/66 311/119 1.0/1.6 17/9 1700/563 5.2/17 2.3/4.4 76/128

Solubility: Miniaturized shake flask solubility in phosphate buffer; fu,plasma from PPB; LM scaled Clint = (LM Clint•SF1•SF2)/1000 with SF1 (mg protein per g liver) m,r = 45, SF2 (g liver per kg BW); m = 87.5, SF2 r = 40. Unbound clearance: Clp = Clu/fu, with Clp observed clearance. Mouse and rat PK 1 mpk IV/3 mpk PO.
分子量

421.83

Formula

C20H18ClF2N3O3

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

20S Proteasome-IN-4 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
20S Proteasome-IN-4
目录号:
HY-151195
需求量: